Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-10

Clinical Trial Update: A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. [Phase 3]

View source ↗

Summary

This document reports the completion and posted results of a Phase 3 study evaluating the safety and efficacy of Xyrem (sodium oxybate) for fibromyalgia. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xyrem (Sodium Oxybate)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2012-01-10